Brief: Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal
20/01/2026 01:15
Jan 20 (Reuters) - Atomo Diagnostics Ltd AT1.AX: EXCLUSIVE LICENCE FOR A NOVEL LIVER FUNCTION TEST ON PASCAL AGREEMENT WITH BURNET DIAGNOSTICS INITIATIVE Further company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt
Brief: Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal
Australia's Atomo Diagnostics jumps on new liver test license